Stay updated with breaking news from Kav Block. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adaptive resynchronization therapy can benefit patients with heart failure, intact atrioventricular conduction, and left bundle branch block, even though the AdaptResponse trial technically failed.
The findings challenge pacing recommendations in HFpEF with chronotropic incompetence and should highlight the disorder's systemic nature, say observers.
A study challenges the dogma of beta-blockers for HF with preserved ejection fraction. For now, the strategy might only be for HFpEF patients already with pacemakers.
Coexisting ECG anomalies may affect the accuracy of the watch’s detection algorithms.
ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death have undergone an important overhaul since the 2015 edition.